{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:18Z","timestamp":1740107598244,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fresenius Medical Care Deutschland GmbH","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00592-019-01296-8","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T23:41:49Z","timestamp":1550187709000},"page":"659-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Agonistic autoantibodies against B2-adrenergic receptors correlating with macrovascular disease in longstanding diabetes type 2"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-8118","authenticated-orcid":false,"given":"Christoph","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-7322","authenticated-orcid":false,"given":"Nicolle","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-0465","authenticated-orcid":false,"given":"Ulrich Alfons","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"issue":"7","key":"1296_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2337\/diacare.21.7.1138","volume":"21","author":"K Gu","year":"1998","unstructured":"Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971\u20131993. Diabetes Care 21(7):1138\u20131145. \n                    https:\/\/doi.org\/10.2337\/diacare.21.7.1138","journal-title":"Diabetes Care"},{"issue":"16","key":"1296_CR2","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990\u20132010. N Engl J Med 370(16):1514\u20131523. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1310799","journal-title":"N Engl J Med"},{"key":"1296_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2458-10-135","volume":"10","author":"L Perna","year":"2010","unstructured":"Perna L, Thien-Seitz U, Ladwig KH, Meisinger C, Mielck A (2010) Socio-economic differences in life expectancy among persons with diabetes mellitus or myocardial infarction: results from the German MONICA\/KORA study. BMC Public health 10:135. \n                    https:\/\/doi.org\/10.1186\/1471-2458-10-135","journal-title":"BMC Public health"},{"issue":"7","key":"1296_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/dme.12747","volume":"32","author":"N Muller","year":"2015","unstructured":"Muller N, Heller T, Freitag MH et al (2015) Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data. Diabet Med 32(7):951\u2013957. \n                    https:\/\/doi.org\/10.1111\/dme.12747","journal-title":"Diabet Med"},{"issue":"7","key":"1296_CR5","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s00125-006-0277-5","volume":"49","author":"I Koster","year":"2006","unstructured":"Koster I, von Ferber L, Ihle P, Schubert I, Hauner H (2006) The cost burden of diabetes mellitus: the evidence from Germany\u2013the CoDiM study. Diabetologia 49(7):1498\u20131504. \n                    https:\/\/doi.org\/10.1007\/s00125-006-0277-5","journal-title":"Diabetologia"},{"issue":"11","key":"1296_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"MS Shah","year":"2016","unstructured":"Shah MS, Brownlee M (2016) Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circulation research 118(11):1808\u20131829. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306923","journal-title":"Circulation research"},{"issue":"22","key":"1296_CR7","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1001\/jama.2010.785","volume":"303","author":"IB Hirsch","year":"2010","unstructured":"Hirsch IB, Brownlee M (2010) Beyond hemoglobin A1c-need for additional markers of risk for diabetic microvascular complications. Jama 303(22):2291\u20132292. \n                    https:\/\/doi.org\/10.1001\/jama.2010.785","journal-title":"Jama"},{"issue":"4","key":"1296_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2337\/db07-1618","volume":"57","author":"JM Lachin","year":"2008","unstructured":"Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN, Group DER (2008) Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2013revisited. Diabetes 57(4):995\u20131001. \n                    https:\/\/doi.org\/10.2337\/db07-1618","journal-title":"Diabetes"},{"issue":"15","key":"1296_CR9","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","volume":"371","author":"S Zoungas","year":"2014","unstructured":"Zoungas S, Chalmers J, Neal B et al (2014) Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 371(15):1392\u20131406. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1407963","journal-title":"N Engl J Med"},{"issue":"5","key":"1296_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCOUTCOMES.116.002901","volume":"9","author":"R Rodriguez-Gutierrez","year":"2016","unstructured":"Rodriguez-Gutierrez R, Montori VM (2016) Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circul Cardiovasc Qual Outcomes 9(5):504\u2013512. \n                    https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.002901","journal-title":"Circul Cardiovasc Qual Outcomes"},{"issue":"1\u20132","key":"1296_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11010-009-0224-0","volume":"333","author":"P Karczewski","year":"2010","unstructured":"Karczewski P, Haase H, Hempel P, Bimmler M (2010) Agonistic antibody to the alpha1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein. Mol Cell Biochem 333(1\u20132):233\u2013242. \n                    https:\/\/doi.org\/10.1007\/s11010-009-0224-0","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"1296_CR12","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1161\/01.CIR.89.6.2760","volume":"89","author":"Y Magnusson","year":"1994","unstructured":"Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89(6):2760\u20132767","journal-title":"Circulation"},{"issue":"2","key":"1296_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.HYP.29.2.678","volume":"29","author":"HP Luther","year":"1997","unstructured":"Luther HP, Homuth V, Wallukat G (1997) Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29(2):678\u2013682. \n                    https:\/\/doi.org\/10.1161\/01.HYP.29.2.678","journal-title":"Hypertension"},{"issue":"11","key":"1296_CR14","doi-asserted-by":"publisher","first-page":"e3742","DOI":"10.1371\/journal.pone.0003742","volume":"3","author":"K Wenzel","year":"2008","unstructured":"Wenzel K, Haase H, Wallukat G et al (2008) Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One 3(11):e3742. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0003742","journal-title":"PLoS One"},{"issue":"8938","key":"1296_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/S0140-6736(94)90456-1","volume":"344","author":"ML Fu","year":"1994","unstructured":"Fu ML, Herlitz H, Wallukat G et al (1994) Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet 344(8938):1660\u20131663. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(94)90456-1","journal-title":"Lancet"},{"issue":"5","key":"1296_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-3083.2012.02684.x","volume":"75","author":"P Karczewski","year":"2012","unstructured":"Karczewski P, Hempel P, Kunze R, Bimmler M (2012) Agonistic autoantibodies to the alpha(1) -adrenergic receptor and the beta(2)\u2014adrenergic receptor in Alzheimer\u2019s and vascular dementia. Scand J Immunol 75(5):524\u2013530. \n                    https:\/\/doi.org\/10.1111\/j.1365-3083.2012.02684.x","journal-title":"Scand J Immunol"},{"issue":"7","key":"1296_CR17","doi-asserted-by":"publisher","first-page":"e41602","DOI":"10.1371\/journal.pone.0041602","volume":"7","author":"P Karczewski","year":"2012","unstructured":"Karczewski P, Pohlmann A, Wagenhaus B et al (2012) Antibodies to the alpha1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography. PLoS One 7(7):e41602. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0041602","journal-title":"PLoS One"},{"issue":"7","key":"1296_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI4106","volume":"103","author":"G Wallukat","year":"1999","unstructured":"Wallukat G, Homuth V, Fischer T et al (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Investig 103(7):945\u2013952. \n                    https:\/\/doi.org\/10.1172\/JCI4106","journal-title":"J Clin Investig"},{"issue":"8","key":"1296_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm.1856","volume":"14","author":"CC Zhou","year":"2008","unstructured":"Zhou CC, Zhang Y, Irani RA et al (2008) Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 14(8):855\u2013862. \n                    https:\/\/doi.org\/10.1038\/nm.1856","journal-title":"Nat Med"},{"issue":"6","key":"1296_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, Muller DN, Brasen JH et al (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352(6):558\u2013569. \n                    https:\/\/doi.org\/10.1056\/NEJMoa035717","journal-title":"N Engl J Med"},{"key":"1296_CR21","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2741\/4698","volume":"23","author":"C Meyer","year":"2018","unstructured":"Meyer C, Heidecke H (2018) Antibodies against GPCR. Front Biosci (Landmark Ed) 23:2177\u20132194","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"1296_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/1744-9987.12415","volume":"20","author":"P Hempel","year":"2016","unstructured":"Hempel P, Heinig B, Jerosch C et al (2016) Immunoadsorption of agonistic autoantibodies against alpha1-adrenergic receptors in patients with mild to moderate dementia. Ther Apheresis Dial 20(5):523\u2013529. \n                    https:\/\/doi.org\/10.1111\/1744-9987.12415","journal-title":"Ther Apheresis Dial"},{"issue":"6","key":"1296_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jca.20263","volume":"25","author":"AO Doesch","year":"2010","unstructured":"Doesch AO, Mueller S, Konstandin M et al (2010) Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy. J Clin Apheresis 25(6):315\u2013322. \n                    https:\/\/doi.org\/10.1002\/jca.20263","journal-title":"J Clin Apheresis"},{"key":"1296_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/loa.1000114","volume":"1","author":"P Klein-Weigel","year":"2016","unstructured":"Klein-Weigel P, Volz TS (2016) Immunoadsorption in Buerger\u2019S Disease (Thromboangiitis Obliterans): a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care. Lupus Open Access 1:2. \n                    https:\/\/doi.org\/10.4172\/loa.1000114","journal-title":"Lupus Open Access"},{"issue":"2","key":"1296_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1365-3083.2009.02280.x","volume":"70","author":"P Hempel","year":"2009","unstructured":"Hempel P, Karczewski P, Kohnert KD et al (2009) Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors. Scand J Immunol 70(2):159\u2013160. \n                    https:\/\/doi.org\/10.1111\/j.1365-3083.2009.02280.x","journal-title":"Scand J Immunol"},{"issue":"3","key":"1296_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00592-018-1100-8","volume":"55","author":"C Werner","year":"2018","unstructured":"Werner C, Muller N, Muller UA (2018) Agonistic autoantibodies against adrenergic receptors correlating with antihypertensive therapy in long-standing diabetes type 2. Acta Diabetol 55(3):301\u2013303. \n                    https:\/\/doi.org\/10.1007\/s00592-018-1100-8","journal-title":"Acta Diabetol"},{"issue":"5","key":"1296_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1024\/0301-1526\/a000372","volume":"43","author":"PF Klein-Weigel","year":"2014","unstructured":"Klein-Weigel PF, Bimmler M, Hempel P et al (2014) G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger\u2019s disease) and their removal by immunoadsorption. VASA Zeitschrift fur Gefasskrankheiten 43(5):347\u2013352. \n                    https:\/\/doi.org\/10.1024\/0301-1526\/a000372","journal-title":"VASA Zeitschrift fur Gefasskrankheiten"},{"issue":"1","key":"1296_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0022-2828(08)80036-3","volume":"27","author":"G Wallukat","year":"1995","unstructured":"Wallukat G, Wollenberger A, Morwinski R, Pitschner HF (1995) Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27(1):397\u2013406. \n                    https:\/\/doi.org\/10.1016\/S0022-2828(08)80036-3","journal-title":"J Mol Cell Cardiol"},{"key":"1296_CR29","unstructured":"Hagen B, Groos S, Kretschmann J, Weber A, Altenhofen L (2015) Qualit\u00e4tssicherungsbericht 2014 Disease-Management-Programme in Nordrhein.36"},{"issue":"4","key":"1296_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1152\/physiol.00014.2013","volume":"28","author":"FC Luft","year":"2013","unstructured":"Luft FC (2013) Activating autoantibodies and cardiovascular disease. Physiology (Bethesda) 28(4):254\u2013261. \n                    https:\/\/doi.org\/10.1152\/physiol.00014.2013","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"1296_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000376546","volume":"131","author":"R Jahns","year":"2015","unstructured":"Jahns R, Boege F (2015) Questionable validity of peptide-based ELISA strategies in the diagnostics of cardiopathogenic autoantibodies that activate G-protein-coupled receptors. Cardiology 131(3):149\u2013150. \n                    https:\/\/doi.org\/10.1159\/000376546","journal-title":"Cardiology"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01296-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:23:15Z","timestamp":1581708195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1296"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01296-8","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"29 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Investigations were substantially financed by Fresenius medical care GmbH, Germany. The sponsor had no influence on study design, data processing or manuscript editing. C.W. received travel funding by Novartis oncology. All authors declare not further conflicting interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All investigations were approved by ethics-committee of the University of Jena (number of decision: 4916-09\/16).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients gave informed consent to laboratory investigations and data processing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}